Maynard Um
-
-
-
-
-
-
-
FDA grants AbbVie's Temab-A two breakthrough therapy designations
-
-
-
-
-
-
-
AbbVie strikes multi-year AI drug discovery deal with Iambic
-
-
-
-
-
-
-
Abbvie (ABBV) PT Raised to $300 at Wells Fargo
-
-
-
-
-
-
-
AbbVie (ABBV) Misses Q2 EPS by 6c, Beats on Revenue; Offers FY26 EPS Guidance
-
-
-
-
-
-
-
Abbvie (ABBV) PT Raised to $300 at BMO Capital
-
-
-
-
-
-
-
U.S. House committee opens investigation into Merck, AbbVie China drug trials - Reuters
-
-
-
-
-
-
-
EU approves AbbVie's Maviret for acute hepatitis C treatment
-
471,951 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


